Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
31 January 2018 Photo Charl Devenish
Kovsie Star of Stars winner believes that Geology rocks
Director of UFS Marketing, Nomonde Mbadi, with the winner of Kovsies Star of Stars for 2017, Palesa Modutwane.

Starting in 2016, UFS Marketing embarked on a project designed to help learners from less fortunate backgrounds to discover their potential. This competition, dubbed ‘Kovsies Star of Stars’, designed to help recognise excellence and reward disadvantaged learners from Quintile 1 to 3 (non-fee-paying) schools. The project’s motto is ‘Aspire to Inspire’, with the goal of discovering the potential hidden beneath the hard-packed surface of poverty.

Two of the five Free State districts were identified, namely Xhariep and Motheo, where the initiative is currently being conducted. In 2016, Grade 12 learners were invited to participate, with ‘Doctor’ Tshepo Thajane, from Lefikeng Secondary School in Botshabelo, being selected as the winner of the inaugural competition. He was pursuing a degree in Actuarial Sciences at the UFS, and towards the end of 2017, he was offered a scholarship to study abroad. This outstanding initiative by the UFS Marketing team was honoured with an award from the organisation Marketing, Advancement, and Communication in Education (MACE) in November 2017.

“We hope to give
… life and hope.”
—Nomonde Mbadi,
Director: UFS Marketing

Initiative seeks to ‘give life and hope’


Nomonde Mbadi, Director of UFS Marketing, whose brainchild the project is, says, “In spite of living in the depths of poverty, taking each day as it comes, these learners have more drive and passion than many others.”

Ms Mbadi and her team, including Chantel Koller, project lead on Star of Stars, aim to "give these learners life and hope" by means of the project, she says.

The winner of the Kovsie Star of Stars for 2017 is Palesa Modutwane from Ipetleng Secondary School in Petrusburg, Free State. She says of her achievement: “This means that all the hard work that I invested in my studies and in community projects is being recognised, and I feel like a new chapter of opportunities has been opened to me. It means that my background does not determine my future. Despite all of this, I still managed to conquer.”

Palesa will be studying Geology at the UFS. After all the hard work getting into her chosen programme, she is up for the challenges and is ready to represent women who were denied the opportunity in a previously male-dominated industry. She says, “I want to show that we have the same potential and wisdom as men.”

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept